Correlation Engine 2.0
Clear Search sequence regions

  • allodynia (2)
  • CCL5 (1)
  • CCL7 (1)
  • CXCL10 (1)
  • CXCL9 (1)
  • drug target (1)
  • ERK (4)
  • G Protein (2)
  • GPCRs (5)
  • GPR151 (13)
  • Gα12 (1)
  • Gα13 (1)
  • Gαi (2)
  • Gαq (1)
  • hyperalgesia (1)
  • kinases (2)
  • mice (6)
  • mitogen (1)
  • neuralgia (2)
  • orphan (3)
  • pain chronic (2)
  • partial (8)
  • pd98059 (1)
  • receptor (3)
  • signal (2)
  • treatment pain (1)
  • Sizes of these terms reflect their relevance to your search.

    Trigeminal nerve injury-induced neuropathic pain is a debilitating chronic orofacial pain syndrome but lacks effective treatment. G protein-coupled receptors (GPCRs), especially orphan GPCRs (oGPCRs) are important therapeutic targets in pain medicine. Here, we screened upregulated oGPCRs in the trigeminal ganglion (TG) after partial infraorbital nerve transection (pIONT) and found that Gpr151 was the most significantly upregulated oGPCRs. Gpr151 mRNA was increased from pIONT day 3 and maintained for more than 21 days. Furthermore, GPR151 was expressed in the neurons of the TG after pIONT. Global mutation or knockdown of Gpr151 in the TG attenuated pIONT-induced mechanical allodynia. In addition, the excitability of TG neurons was increased after pIONT in wild-type (WT) mice, but not in Gpr151-/- mice. Notably, GPR151 bound to Gαi protein, but not Gαq, Gα12, or Gα13, and activated the extracellular signal-regulated kinase (ERK) through Gβγ. Extracellular signal-regulated kinase was also activated by pIONT in the TG of WT mice, but not in Gpr151-/- mice. Gene microarray showed that Gpr151 mutation reduced the expression of a large number of neuroinflammation-related genes that were upregulated in WT mice after pIONT, including chemokines CCL5, CCL7, CXCL9, and CXCL10. The mitogen-activated protein kinase inhibitor (PD98059) attenuated mechanical allodynia and reduced the upregulation of these chemokines after pIONT. Collectively, this study not only revealed the involvement of GPR151 in the maintenance of trigeminal neuropathic pain but also identified GPR151 as a Gαi-coupled receptor to induce ERK-dependent neuroinflammation. Thus, GPR151 may be a potential drug target for the treatment of trigeminal neuropathic pain. Copyright © 2020 International Association for the Study of Pain.


    Bao-Chun Jiang, Jing Zhang, Bin Wu, Ming Jiang, Hanzhong Cao, Hao Wu, Yong-Jing Gao. G protein-coupled receptor GPR151 is involved in trigeminal neuropathic pain through the induction of Gβγ/extracellular signal-regulated kinase-mediated neuroinflammation in the trigeminal ganglion. Pain. 2021 May 01;162(5):1434-1448

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33239523

    View Full Text